Vikram Karnani
CEO, President & DirectorMr. Vikram Karnani is Independent Director of Dyne Therapeutics, Inc. from December 22, 2025. Mr. Karnani is CEO, President & Director of Collegium Pharmaceutical, Inc. since November 12, 2024 and served as its Executive Vice President. Mr. Karnani was Executive Vice President and President, Global Commercial Operations and Medical Affairs (Rare Disease) at Amgen Inc. He served as President of Medical Affairs at Horizon Therapeutics Public Limited Company since August 2022 and was its President of Global Commercial Operations since 2023 and was its Executive Vice President since March 2018 and was its President of International since August 2022 until 2023. He was Executive Vice President and President of International Operations at Horizon Therapeutics Public Limited Company since August 2020 until August 2022. Prior to that, he served as Chief Commercial Officer at Horizon Therapeutics Public Limited Company from March 2018 to August 2020, as Senior Vice President, rheumatology business unit from February 2017 to March 2018 and as General Manager, specialty business unit from July 2014 until February 2017. Mr. Karnani served as Senior Vice President of Rheumatology Business Unit at Horizon Pharma Public Limited Company from February 2017 to March 2018 and served as its Group Vice President and General Manager of Rheumatology Business Unit July 2014 and December 18, 2015 respectively. Prior to joining Horizon in July 2014, Mr. Karnani served with Fresenius Kabi, where he served as Vice President of the Therapeutics and Cell Therapy business from October 2011 to July 2014, with a focus on sales, marketing and clinical implementation. Mr. Karnani also held various positions in business development, corporate strategy and strategic marketing within Fenwal Inc. was acquired by Fresenius Kabi from November 2008 to October 2011. Mr. Karnani has many years of cross functional expertise across a multitude of industries, including medical devices, management consulting, semiconductors and cellular telecommunications. Mr. Karnani has an MBA from the Kellogg School of Management at Northwestern University, a master's science in Electrical Engineering from Case Western Reserve University and a bachelor of science degree in Electrical Engineering from University of Bombay, India.
Positions
- Company NameCollegium Pharmaceutical, Inc.Stock CodeCOLLPositionCEO, President & DirectorColleagues
- GSGino SantiniIndependent Chairman
- CTColleen TupperExecutive VP & CFO
- DDDavid DieterExecutive VP, General Counsel & Corporate Secretary
- TBThomas B. SmithExecutive VP & Chief Medical Officer
- IKIan KarpHead of Investor Relations
- GGGaren G. BohlinIndependent Director
- RJRita J. Balice-GordonIndependent Director
- NSNancy S. LurkerIndependent Director
